$1.07
At close: May 19 EDT
$1.00
-0.07-6.54%
Pre-Market: 7:23 AM EDT
Comments
Loading...
XORTX Therapeutics (XRTX) Forecast
NewsEarningsXORTX Therapeutics (XRTX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
XORTX Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:XRTX | Benzinga
Explore XORTX Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for XRTX.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy XORTX Therapeutics (XRTX) stock?
You can purchase shares of XORTX Therapeutics (NASDAQ:XRTX) through any online brokerage.
Who are XORTX Therapeutics (XRTX) competitors?
There are no as such competitors for XORTX Therapeutics.
What is the forecast, or price target, for XORTX Therapeutics (XRTX) stock?
XORTX Therapeutics has a consensus price target of $14.00.
What is the current price for XORTX Therapeutics (XRTX)?
The stock price for XORTX Therapeutics (NASDAQ: XRTX) is $1 last updated May 19, 2025 at 7:23 AM EDT.
Does XORTX Therapeutics (XRTX) pay a dividend?
A quarterly cash dividend of 0.07 per share of Class A Common Stock. The quarterly cash dividend was payable on February 17, 2014 to stockholders of record on January 31, 2014.
When is XORTX Therapeutics (NASDAQ:XRTX) reporting earnings?
XORTX Therapeutics’s Q2 earnings are confirmed for Wednesday, August 13, 2025.
Is XORTX Therapeutics (XRTX) going to split?
There is no upcoming split for XORTX Therapeutics.
What sector and industry does XORTX Therapeutics (XRTX) operate in?
XORTX Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
